KFRC:NYSEKforce, Inc. Analysis
Data as of 2026-04-12 - not real-time
$28.23
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Kforce (KFRC) is trading at $28.23, just above its 20‑day SMA of $28.08 but below the 50‑day ($29.08) and 200‑day ($31.86) averages, signaling short‑term support amid a longer‑term bearish backdrop. The RSI sits near 48, indicating neutral momentum, while a bullish MACD histogram (+0.20) suggests a possible near‑term price lift despite decreasing volume and a 30‑day volatility of over 35%. Fundamentally, the stock trades at a forward P/E of 10.3 versus an industry average of 30.9, and a DCF‑derived fair value of $39.80 points to roughly 38% upside potential. The dividend yield is an attractive 5.56% with a payout ratio near 80%, supported by solid free cash flow of $59.7 M, though cash on hand is modest and debt‑to‑equity stands at 66.6%. Recent Q4 earnings showed a 3.4% revenue decline and thin operating margins, underscoring the need for top‑line growth. Upcoming Q1 results on April 27 could act as a catalyst, especially given the “Extreme Greed” market sentiment reflected in the fear‑greed index. Overall, the valuation gap and dividend appeal are compelling, but the high leverage and volatile price action warrant caution.
Recommendation: Hold in the short term pending earnings, move to a modest buy position for the medium horizon to capture the valuation upside, and maintain a watchful hold stance long‑term as the company balances cash flow generation against debt and modest growth prospects.
Recommendation: Hold in the short term pending earnings, move to a modest buy position for the medium horizon to capture the valuation upside, and maintain a watchful hold stance long‑term as the company balances cash flow generation against debt and modest growth prospects.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Upcoming Q1 earnings could swing price
- Technical price near short‑term support
- High dividend yield offsets near‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation upside vs DCF fair value
- Strong free cash flow and attractive dividend
- Forward P/E well below industry average
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable dividend supported by cash flow
- Elevated debt levels and modest revenue growth
- Industry cyclicality and potential regulatory changes
Key Metrics & Analysis
Financial Health
Revenue Growth-3.40%
Profit Margin2.62%
P/E Ratio14.4
ROE24.94%
ROA8.65%
Debt/Equity66.57
P/B Ratio3.9
Op. Cash Flow$61.6M
Free Cash Flow$59.7M
Industry P/E30.9
Technical Analysis
TrendBearish
RSI47.8
Support$25.46
Resistance$30.50
MA 20$28.08
MA 50$29.08
MA 200$31.86
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
Fair Value$39.81
Target Price$39.00
Upside/Downside38.15%
GradeUndervalued
TypeValue
Dividend Yield5.56%
Risk Assessment
Beta0.63
Volatility35.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.